Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05014555 |
|
Recruitment Status :
Not yet recruiting
First Posted : August 20, 2021
Last Update Posted : June 18, 2023
|
Sponsor:
GI Alliance
Collaborators:
Janssen, LP
University of Wisconsin, Madison
Mayo Clinic
Information provided by (Responsible Party):
GI Alliance
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2024 |
| Estimated Study Completion Date : | January 2024 |